Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 306

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid Autoantigen

Open access
Alimohammadi, Mohammad, Björklund, Peyman, Hallgren, Åsa, Pöntynen, Nora, Szinnai, Gabor, Shikama, Noriko, Keller, Marcel P., Ekwall, Olov, Kinkel, Sarah A., Husebye, Eystein S., Gustafsson, Jan, Rorsman, Fredrik, Peltonen, Leena, Betterle, Corrado, Perheentupa, Jaakko, Åkerström, Göran, Westin, Gunnar, Scott, Hamish S., Holländer, Georg A., Kämpe, Olle·2008·New England Journal of Medicine

Abstract

BACKGROUND: Autoimmune polyendocrine syndrome type 1 (APS-1) is a multiorgan autoimmune disorder caused by mutations in AIRE, the autoimmune regulator gene. Though recent studies concerning AIRE deficiency have begun to elucidate the molecular pathogenesis of organ-specific autoimmunity in patients with APS-1, the autoantigen responsible for hypoparathyroidism, a hallmark of APS-1 and its most common autoimmune endocrinopathy, has not yet been identified. METHODS: We performed immunoscreening of a human parathyroid complementary DNA library, using serum samples from patients with APS-1 and hypoparathyroidism, to identify patients with reactivity to the NACHT leucine-rich-repeat protein 5 (NALP5). Subsequently, serum samples from 87 patients with APS-1 and 293 controls, including patients with other autoimmune disorders, were used to determine the frequency and specificity of autoantibodies against NALP5. In addition, the expression of NALP5 was investigated in various tissues. RESULTS: NALP5-specific autoantibodies were detected in 49% of the patients with APS-1 and hypoparathyroidism but were absent in all patients with APS-1 but without hypoparathyroidism, in all patients with other autoimmune endocrine disorders, and in all healthy controls. NALP5 was predominantly expressed in the cytoplasm of parathyroid chief cells. CONCLUSIONS: NALP5 appears to be a tissue-specific autoantigen involved in hypoparathyroidism in patients with APS-1. Autoantibodies against NALP5 appear to be highly specific and may be diagnostic for this prominent component of APS-1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa0706487

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 306

Metadata

Authors
Alimohammadi, M., Björklund, P., Hallgren, Å., Pöntynen, N., Szinnai, G., Shikama, N., Keller, M. P., Ekwall, O., Kinkel, S. A., Husebye, E. S., Gustafsson, J., Rorsman, F., Peltonen, L., Betterle, C., Perheentupa, J., Åkerström, G., Westin, G., Scott, H. S., Holländer, G. A., & Kämpe, O.
Venue
New England Journal of Medicine
Published
2008-03-06
Volume
358
Issue
10
Pages
1018-1028
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2135200130
Cited by
306
References
26
FWCI
11.14
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid Autoantigen. https://app.cochat.ai/papers/10.1056/nejmoa0706487
The paper
Alimohammadi, M., Björklund, P., Hallgren, Å., Pöntynen, N., Szinnai, G., Shikama, N., Keller, M. P., Ekwall, O., Kinkel, S. A., Husebye, E. S., Gustafsson, J., Rorsman, F., Peltonen, L., Betterle, C., Perheentupa, J., Åkerström, G., Westin, G., Scott, H. S., Holländer, G. A., & Kämpe, O. (2008). Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid Autoantigen. New England Journal of Medicine. https://doi.org/10.1056/nejmoa0706487

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.